Black Race Predicts Poor Compliance and Higher Prostate Cancer Risk in a Multinational Repeat Biopsy Cohort: Secondary Analysis From the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Clinical Trial - Alexis R. Freedland; Daniel M. Moriera; Jun Gong; Stephen J. Freedland (The Prostate, 2026)